The global hematopoietic stem cell transplantation market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). This transplantation is termed as a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow, or umbilical cord blood are transplanted into a patient. The primary factor such as the rising number of hematopoietic stem cell transplants is likely to propel the market growth during the forecast period. Moreover, the increasing cases of lymphoma and leukemia are driving the growth of the market. Further, the advent of personalized medicine coupled with their growing adoption to treat several chronic diseases is further anticipated to provide a boost to the market.
To Request a Sample of our Report on Hematopoietic Stem Cell Transplantation Market: https://www.omrglobal.com/request-sample/hematopoietic-stem-cell-transplantation-market
Another major trend observed in the market includes the formation of strong allies and a network of hematopoietic stem cells transplantation organizations having global reach and presence. For instance, Worldwide Network for Blood and Marrow Transplantation Group (WBMT) in official relation with World Health Organization (WHO) conducts various campaigns that ultimately aim at creating awareness regarding stem cells transplantation among people. However, the lack of funding for WBMT and other organizations serves as a major restraint to the market apart from the high cost of transplantation. Additionally, several research organizations are focusing on the development of personalized medicines that are effective in offering treatment on the basis of patients’ preferences. The key benefits of such personalized medicine that positively influence the market growth include the low risk of immune rejection, reduced need for anti-rejection drugs, absence of the need for embryonic stem cells, and less chance of developing GvHD.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Transplant Type
· By Indication
· By Application
• Regions covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape: Lonza Group, Merck & Co., Inc., and Pluristem Therapeutics, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Hematopoietic Stem Cell Transplantation Market is Available @ https://www.omrglobal.com/industry-reports/hematopoietic-stem-cell-transplantation-market
Global Hematopoietic Stem Cell Transplantation Market Report by Segment
By Transplant Type
· Allogenic
· Autologous
By Indication
· Acute Myeloid Leukemia (AML)
· Acute Lymphoblastic Leukemia (ALL)
· Hodgkin lymphoma (HL)
· Non-Hodgkin Lymphoma (NHL)
· Multiple Myeloma (MM)
· Others
By Application
· Bone Marrow Transplant (BMT)
· Peripheral Blood Stem Cells Transplant (PBSCT)
· Others
Global Hematopoietic Stem Cell Transplantation Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
